VIRALEZE to be launched with LloydsPharmacy in the UK
Filed with ASX · · 4 pages · English
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- DEP HER2-lutetium outperforms in human breast cancer model
- VIRALEZE antiviral nasal spray registered in Europe
- Starpharma signs DEP ADC Research Agreement with MSD
- AZD0466 clinical DEP program global expansion
- Change in substantial holding
Later from Starpharma
- VIRALEZE™ now launched by LloydsPharmacy in the UK
- VIRALEZE launches in Europe
- VIRALEZE SPL7013 highly active in UK variant of coronavirus
- VIRALEZE antiviral nasal spray registered for sale in India
- VIRALEZE SPL7013 virucidal against multiple COVID variants
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma